@article{3361b887e1324f33933c0022c973a849,
title = "Break the lifeline of AML cells",
author = "Yoko Tabe and Marina Konopleva",
note = "Funding Information: Conflict-of-interest disclosure: Y.T. reports grants and other support from Sysmex, Kohjin Bio, and Roche Diagnostics. M.K. reports grants and other support outside the submitted work from AbbVie, F. Hoffman-La Roche, Stemline Therapeutics, Forty-Seven, and Genentech; grants outside the submitted work from Eli Lilly, Cellectis, Calithera, Ablynx, Agios, Ascentage, AstraZeneca, Rafael Pharmaceutical, and Sanofi; and other support from Reata Pharmaceuticals and Janssen. In addition, M.K. has patents US 7,795,305 B2 “CDDO-compounds and combination therapies thereof” with royalties paid to Reata Pharmaceuticals; “Combination therapy with a mutant IDH1 inhibitor and a BCL-2” licensed to Eli Lilly, and 62/993,166 “Combination of a MCL-1 inhibitor and midostaurin, uses and pharmaceutical compositions thereof” pending to Novartis. Funding Information: Conflict-of-interest disclosure: Y.T. reports grants and other support from Sysmex, Kohjin Bio, and Roche Diagnostics. M.K. reports grants and other support outside the submitted work from AbbVie, F. Hoffman-La Roche, Stemline Therapeutics, Forty-Seven, and Genentech; grants outside the submitted work from Eli Lilly, Cellectis, Calithera, Ablynx, Agios, Ascentage, AstraZeneca, Rafael Pharmaceutical, and Sanofi; and other support from Reata Pharmaceuticals and Janssen. In addition, M.K. has patents US 7,795,305 B2 ?CDDO-compounds and combination therapies thereof? with royalties paid to Reata Pharmaceuticals; ?Combination therapy with a mutant IDH1 inhibitor and a BCL-2? licensed to Eli Lilly, and 62/993,166 ?Combination of a MCL-1 inhibitor and midostaurin, uses and pharmaceutical compositions thereof? pending to Novartis.",
year = "2021",
month = jun,
day = "24",
doi = "10.1182/blood.2021011475",
language = "English (US)",
volume = "137",
pages = "3465--3467",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "25",
}